企業プロフィール
Ibio Inc 株価・ニュース・カタリスト
- ティッカー:
- IBIO
- 取引所:
- AMEX
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
1.45 USD (+1.40%)
終値
最終更新: 2026年8月17日
87.4M USD
時価総額
株価変動の要因
As of Aug 17, 2026, IBIO closed up 1.40% at $1.45. No new same-company headline was identified in the current news window.
企業概要
AI-Enabled Antibody Discovery
iBio develops antibodies using computational discovery and engineering platforms designed to improve target selection and molecular properties.
IBIO-600
IBIO-600 is a long-acting anti-myostatin antibody intended to preserve lean mass and improve body composition during obesity treatment.
Cardiopulmonary Expansion
The pipeline also includes a bispecific antibody program for pulmonary hypertension associated with heart failure with preserved ejection fraction.
今後のカタリスト
- iBio has received Australian regulatory clearance to initiate a first-in-human Phase 1 study of IBIO-600.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。